CARACTERIZAÇÃO DOS EFEITOS ANTINEOPLÁSICO DE UM POTENCIAL INIBIDOR HÍBRIDO PARA HDAC E BTK EM LEUCEMIA LINFOIDE CRÔNICA (LLC): EXPLORANDO SINERGIAS TERAPÊUTICAS COM VENETOCLAX

Autor: ADMB Garnique, JAEG Carlos, K Lima, NS Parducci, MT Tavares, KB Waitman, LV Cost-Lotufo, R Paris-Filho, JA Machad-Neto

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S155-S156 (2023)

A Leucemia linfoide crônica (LLC) é uma condição caracterizada pelo aumento na produção de linfócitos B maduros CD5+ no sangue, medula óssea, baço e tecidos linfoides. Essas células, no entanto, são disfuncionais devido a alterações gen�

Externí odkaz: https://doaj.org/article/c777e3927024471384f545aa7a397758

PURINE-DERIVED PHENYLHYDROXAMATE COMPOUNDS INDUCES CELL DEATH IN HEMATOLOGICAL NEOPLASM MODELS

Autor: JAEG Carlos, LC Almeida, K Lima, MT Tavares, KB Waitman, LV Costa-Lotufo, R Parise-Filho, JA Machado-Neto

Publikováno v: Hematology, Transfusion and Cell Therapy. 44:S157-S158

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ccef3e743f52d41d664b7f60ec661fed
https://doi.org/10.1016/j.htct.2022.09.265

Occurrence of Lysiphlebus testaceipes (Cresson, 1880) (Hymenoptera: Braconidae: Aphidiinae) parasitizing Aphis forbesi Weed, 1889 (Hemiptera: Aphididae) in the strawberries crop in the metropolitan Region of Curitiba, Parana, Brazil

Autor: ES. Araujo, MAC. Zawadneak, MT. Tavares, A. Benatto, ÁF. Mógor

Publikováno v: Brazilian Journal of Biology, Vol 73, Iss 1, Pp 221-222 (2013)

Externí odkaz: https://doaj.org/article/46ce48d9ed204f79b0276b42f029abb8

Sustainable production of porous chitosan microparticles by energy-efficient membrane emulsification.

Autor: Mondal S; LAQV/Requimte, Department of Chemistry, NOVA School of Science and Technology, FCT NOVA, Universidade NOVA de Lisboa, 2829-516, Caparica, Portugal., Tavares MT; LAQV/Requimte, Department of Chemistry, NOVA School of Science and Technology, FCT NOVA, Universidade NOVA de Lisboa, 2829-516, Caparica, Portugal., Brazinha C; LAQV/Requimte, Department of Chemistry, NOVA School of Science and Technology, FCT NOVA, Universidade NOVA de Lisboa, 2829-516, Caparica, Portugal.

Publikováno v: Heliyon [Heliyon] 2024 May 23; Vol. 10 (11), pp. e31823. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).

1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.

Autor: Tavares MT; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA., Krüger A; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1374, São Paulo, 05508-900, Brazil., Yan SLR; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1374, São Paulo, 05508-900, Brazil., Waitman KB; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 580, São Paulo, 05508-000, Brazil., Gomes VM; GlycoProteomics Laboratory, Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.; School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, Australia., de Oliveira DS; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1374, São Paulo, 05508-900, Brazil., Paz F; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1374, São Paulo, 05508-900, Brazil., Hilscher S; Faculty of Biosciences, Martin-Luther-University of Halle-Wittenberg, 06120, Halle/Saale, Germany., Schutkowski M; Faculty of Biosciences, Martin-Luther-University of Halle-Wittenberg, 06120, Halle/Saale, Germany., Sippl W; Faculty of Biosciences, Martin-Luther-University of Halle-Wittenberg, 06120, Halle/Saale, Germany., Ruiz C; Department of Molecular Medicine, The Herbert Wertheim Institute for Biomedical Innovation and Technology, Jupiter, FL, 33458, USA., Toledo MFZJ; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 580, São Paulo, 05508-000, Brazil., Hassimotto NMA; Food Research Center-(FoRC-CEPID) and Department of Food Science and Nutrition, Faculty of Pharmaceutical Science, University of São Paulo, São Paulo, SP, Brazil., Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Poso A; Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard-Karls-Universität, Tuebingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.; Tuebingen Center for Academic Drug Discovery & Development (TüCAD2), 72076, Tübingen, Germany.; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland., Cameron MD; Department of Molecular Medicine, The Herbert Wertheim Institute for Biomedical Innovation and Technology, Jupiter, FL, 33458, USA., Bannister TD; Department of Molecular Medicine, The Herbert Wertheim Institute for Biomedical Innovation and Technology, Jupiter, FL, 33458, USA., Palmisano G; GlycoProteomics Laboratory, Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.; School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, Australia., Wrenger C; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1374, São Paulo, 05508-900, Brazil. cwrenger@icb.usp.br., Kronenberger T; Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard-Karls-Universität, Tuebingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany. thales.kronenberger@uni-tuebingen.de.; Tuebingen Center for Academic Drug Discovery & Development (TüCAD2), 72076, Tübingen, Germany. thales.kronenberger@uni-tuebingen.de.; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. thales.kronenberger@uni-tuebingen.de., Parise-Filho R; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 580, São Paulo, 05508-000, Brazil. roberto.parise@usp.br.

Publikováno v: Scientific reports [Sci Rep] 2023 Nov 29; Vol. 13 (1), pp. 21006. Date of Electronic Publication: 2023 Nov 29.